Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients

被引:32
作者
Chevallier, Patrice [1 ,2 ,5 ]
Coste-Burel, Marianne [3 ]
Le Bourgeois, Amandine [1 ]
Peterlin, Pierre [1 ]
Garnier, Alice [1 ]
Bene, Marie C. [3 ,4 ]
Imbert, Berthe-Marie [2 ]
Drumel, Thomas [3 ]
Le Gouill, Steven [1 ]
Moreau, Philippe [1 ]
Mahe, Beatrice [1 ]
Dubruille, Viviane [1 ]
Blin, Nicolas [1 ]
Lok, Anne [1 ]
Touzeau, Cyrille [1 ]
Gastinne, Thomas [1 ]
Jullien, Maxime [1 ]
Vanthygem, Sophie [1 ]
Guillaume, Thierry [1 ,2 ]
机构
[1] Nantes Univ Hosp, Dept Hematol, Nantes, France
[2] Univ Nantes, INSERM UMR1232, CRCINA IRS UN, Nantes, France
[3] Nantes Univ Hosp, Dept Virol, Nantes, France
[4] Nantes Univ Hosp, Dept Hematol Biol, Nantes, France
[5] CHU Hotel Dieu, Serv Hematol Clin, Pl A Ricordeau, F-44093 Nantes, France
来源
EJHAEM | 2021年 / 2卷 / 03期
关键词
RISK-FACTORS; MULTICENTER; COVID-19;
D O I
10.1002/jha2.242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplanted patients compared to 100% for the controls (p < 0.001). Factors influencing the absence of response in patients were recent transplantation (<2 years), lymphopenia (<1 x 10(9)/L) and immunosuppressive treatment or chemotherapy at the time of vaccination.
引用
收藏
页码:520 / 524
页数:5
相关论文
共 13 条
[1]  
Agha M, 2021, medRxiv, DOI [10.1101/2021.04.06.21254949, 10.1101/2021.04.06.21254949, DOI 10.1101/2021.04.06.21254949]
[2]   Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients [J].
Benotmane, Ilies ;
Gautier-Vargas, Gabriela ;
Cognard, Noelle ;
Olagne, Jerome ;
Heibel, Francoise ;
Braun-Parvez, Laura ;
Martzloff, Jonas ;
Perrin, Peggy ;
Moulin, Bruno ;
Fafi-Kremer, Samira ;
Caillard, Sophie .
KIDNEY INTERNATIONAL, 2021, 99 (06) :1487-1489
[3]  
Boyarsky BJ., 2021, JAMA, V325
[4]   Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines [J].
Chapin-Bardales, Johanna ;
Gee, Julianne ;
Myers, Tanya .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21) :2201-2202
[5]   Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept [J].
Chavarot, Nathalie ;
Ouedrani, Amani ;
Marion, Olivier ;
Leruez-Ville, Marianne ;
Vilain, Estelle ;
Baaziz, Maroua ;
Del Bello, Arnaud ;
Burger, Carole ;
Sberro-Soussan, Rebecca ;
Martinez, Frank ;
Chatenoud, Lucienne ;
Abravanel, Florence ;
Anglicheau, Dany ;
Izopet, Jacques ;
Couat, Chloe ;
Zuber, Julien ;
Legendre, Christophe ;
Lanternier, Fanny ;
Kamar, Nassim ;
Scemla, Anne .
TRANSPLANTATION, 2021, 105 (09) :E94-E95
[6]   2017 ECIL 7 vaccine guidelines [J].
Cordonnier, Catherine ;
Mikulska, Malgorzata ;
Einarsdottir, Sigrun ;
Cesaro, Simone ;
Ljungman, Per .
LANCET INFECTIOUS DISEASES, 2019, 19 (07) :694-695
[7]   Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study [J].
Garcia-Suarez, Julio ;
de la Cruz, Javier ;
Cedillo, Angel ;
Llamas, Pilar ;
Duarte, Rafael ;
Jimenez-Yuste, Victor ;
Hernandez-Rivas, Jose Angel ;
Gil-Manso, Rodrigo ;
Kwon, Mi ;
Sanchez-Godoy, Pedro ;
Martinez-Barranco, Pilar ;
Colas-Lahuerta, Blanca ;
Herrera, Pilar ;
Benito-Parra, Laurentino ;
Alegre, Adrian ;
Velasco, Alberto ;
Matilla, Arturo ;
Alaez-Uson, Maria Concepcion ;
Martos-Martinez, Rafael ;
Martinez-Chamorro, Carmen ;
Susana-Quiroz, Keina ;
Del Campo, Juan Francisco ;
de la Fuente, Adolfo ;
Herraez, Regina ;
Pascual, Adriana ;
Gomez, Elvira ;
Perez-Oteyza, Jaime ;
Ruiz, Elena ;
Alonso, Arancha ;
Gonzalez-Medina, Jose ;
Martin-Buitrago, Lucia Nunez ;
Canales, Miguel ;
Gonzalez-Gascon, Isabel ;
Vicente-Ayuso, Maria Carmen ;
Valenciano, Susana ;
Roa, Maria Garcia ;
Monteliu, Pablo Estival ;
Lopez-Jimenez, Javier ;
Escobar, Cristian Escolano ;
Ortiz-Martin, Javier ;
Diez-Martin, Jose Luis ;
Martinez-Lopez, Joaquin .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[8]   Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia [J].
Herishanu, Yair ;
Avivi, Irit ;
Aharon, Anat ;
Shefer, Gabi ;
Levi, Shai ;
Bronstein, Yotam ;
Morales, Miguel ;
Ziv, Tomer ;
Arbel, Yamit Shorer ;
Scarfo, Lydia ;
Joffe, Erel ;
Perry, Chava ;
Ghia, Paolo .
BLOOD, 2021, 137 (23) :3165-3173
[9]   Vaccination of immunocompromised patients [J].
Ljungman, Per .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 :93-99
[10]   Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study [J].
Passamonti, Francesco ;
Cattaneo, Chiara ;
Arcaini, Luca ;
Bruna, Riccardo ;
Cavo, Michele ;
Merli, Francesco ;
Angelucci, Emanuele ;
Krampera, Mauro ;
Cairoli, Roberto ;
Della Porta, Matteo Giovanni ;
Fracchiolia, Nicola ;
Ladetto, Marco ;
Passerini, Carlo Gambacorti ;
Salvini, Marco ;
Marchetti, Monia ;
Lemoli, Roberto ;
Molteni, Alfredo ;
Busca, Alessandro ;
Cuneo, Antonio ;
Romano, Alessandra ;
Giuliani, Nicola ;
Galimberti, Sara ;
Corso, Alessandro ;
Morotti, Alessandro ;
Falini, Brunangelo ;
Billio, Atto ;
Gherlinzoni, Filippo ;
Visani, Giuseppe ;
Tisi, Maria Chiara ;
Tafuri, Agostino ;
Tosi, Patrizia ;
Lanza, Francesco ;
Massaia, Massimo ;
Turrini, Mauro ;
Ferrara, Felicetto ;
Gurrieri, Carmela ;
Vallisa, Daniele ;
Martelli, Maurizio ;
Derenzini, Enrico ;
Guarini, Attilio ;
Conconi, Annarita ;
Cuccaro, Annarosa ;
Cudillo, Laura ;
Russo, Domenico ;
Ciambelli, Fabrizio ;
Scattolin, Anna Maria ;
Luppi, Mario ;
Selleri, Carmine ;
La Barbera, Elettra Ortu ;
Ferrandina, Celestino .
LANCET HAEMATOLOGY, 2020, 7 (10) :E737-E745